NCT07806188

Brief Summary

This retrospective cohort study will include 412 adults mechanically ventilated \>24 hours in intensive care unit in sohag university hospital between 2024 and 2026). Participants will be assigned to either, EGDS group ( equal to 208 ) or conventional sedation group (equal to 204 ). The main endpoint will be measured is the incidence of delirium in ICU , measured by the Confusion Assessment Method for the ICU (CAM-ICU). Secondary endpoints will be the number of the days free from ventilation at 28 days (VFDs), ICU length of stay (LOS) in the ICU, and the death during hospitalization.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
412

participants targeted

Target at P75+ for all trials

Timeline
3mo left

Started Aug 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Aug 2026Jan 2027

Study Start

First participant enrolled

August 20, 2026

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

August 24, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 8, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2027

Last Updated

September 8, 2026

Status Verified

August 1, 2026

Enrollment Period

2 months

First QC Date

August 24, 2026

Last Update Submit

September 1, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • occurrence of delirium during the ICU admission

    main end point: occurrence of delirium during the ICU admission , defined as at least one positive CAM-ICU assessment.

    Within 12 hours of intubation

Secondary Outcomes (2)

  • Number of Ventilator-free days (VFDs)

    6 months

  • duration of ICU stay (LOS)

    6 months

Study Arms (2)

EGDS Group: Patients managed per the institutional EGDS protocol initiated within 12 hours of intuba

· EGDS Group: Patients managed per the institutional EGDS protocol initiated within 12 hours of intubation. The protocol mandated: a) Primary sedative: Dexmedetomidine infusion (loading dose optional, maintenance 0.2-1.5 µg/kg/hr). b) Goal: Target Richmond Agitation-Sedation Scale (RASS) score of 0 to -2. c) Adjunct Analgesia: Scheduled acetaminophen and opioid infusion (e.g., fentanyl) for pain control (CPOT target \<3). d) Protocol Deviations: Propofol was allowed as a rescue for refractory agitation (RASS \>+2) after optimizing analgesia

Conventional Sedation Group: Patients managed at the discretion of the treating intensivist without

Conventional Sedation Group: Patients managed at the discretion of the treating intensivist without a mandated protocol. This typically involved continuous infusions of propofol and/or midazolam, with or without dexmedetomidine, with variable RASS targets

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

this retrospective observational trial was conducted in a 40-bed intensive care unit at sohag university hospital between January 2024, to ,march 2026. The Institutional Review Board granted approval for the trial protocol and informed consent was waived

You may qualify if:

  • Consecutive adult patients aged 18 years or older who required invasive mechanical ventilation for more than 24 hours.

You may not qualify if:

  • Neurological primary admission such as stroke or traumatic brain injury.
  • Active seizures or alcohol withdrawal at admission.
  • Prior dementia or severe cognitive impairment.
  • Mechanical ventilation \<24 hours.
  • Death within 48 hours of admission.
  • Missing essential sedation or delirium data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor of Anesthesia and Intensive Care

Study Record Dates

First Submitted

August 24, 2026

First Posted

September 8, 2026

Study Start

August 20, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

January 20, 2027

Last Updated

September 8, 2026

Record last verified: 2026-08